Sougawa, N., Miyagawa, S., Fukushima, S., Kawamura, A., Yokoyama, J., Ito, E., . . . Sawa, Y. (2018). Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy. Nature Portfolio.
Style de citation Chicago (17e éd.)Sougawa, Nagako, et al. Immunologic Targeting of CD30 Eliminates Tumourigenic Human Pluripotent Stem Cells, Allowing Safer Clinical Application of HiPSC-based Cell Therapy. Nature Portfolio, 2018.
Style de citation MLA (8e éd.)Sougawa, Nagako, et al. Immunologic Targeting of CD30 Eliminates Tumourigenic Human Pluripotent Stem Cells, Allowing Safer Clinical Application of HiPSC-based Cell Therapy. Nature Portfolio, 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.